-
Mashup Score: 0Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease - 8 month(s) ago
Did you know that intravascular and extravascular hemolyses are the 2 hemolytic pathways underlying paroxysmal nocturnal hemoglobinuria (PNH)?
Source: www.medscape.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease - 8 month(s) ago
Did you know that intravascular and extravascular hemolyses are the 2 hemolytic pathways underlying paroxysmal nocturnal hemoglobinuria (PNH)?
Source: www.medscape.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Home - 8 month(s) ago
In this live, interactive program, expert faculty will present and discuss the most recent data and clinical advances as well as provide expert perspectives on optimal clinical decision-making for three rare, complex hematologic disorders marked by dysfunction of the complement cascade: atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA). Clinical case vignettes will be highlighted
Source: na.eventscloud.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Home > PNH > FDA Accepts Application for Novel Treatment of Paroxysmal Nocturnal Hemoglobinuria The US Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for crovalimab, a novel, investigational, anti-C5 recycling antibody developed to treat paroxysmal nocturnal hemoglobinuria (PNH). “This filing acceptance reinforces the value of crovalimab, which was engineered to be recy cled in the bloodstream, with the goal of offering a sustained response while reducing treatment
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Home - 9 month(s) ago
In this live, interactive program, expert faculty will present and discuss the most recent data and clinical advances as well as provide expert perspectives on optimal clinical decision-making for three rare, complex hematologic disorders marked by dysfunction of the complement cascade: atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA). Clinical case vignettes will be highlighted
Source: na.eventscloud.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease - 9 month(s) ago
Did you know that intravascular and extravascular hemolyses are the 2 hemolytic pathways underlying paroxysmal nocturnal hemoglobinuria (PNH)?
Source: www.medscape.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease - 10 month(s) ago
Did you know that intravascular and extravascular hemolyses are the 2 hemolytic pathways underlying paroxysmal nocturnal hemoglobinuria (PNH)?
Source: www.medscape.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 15Blood Cancer Talks: Episode 27. Management of PNH on Apple Podcasts - 10 month(s) ago
Show Blood Cancer Talks, Ep Episode 27. Management of PNH – Jul 31, 2023
Source: podcasts.apple.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease - 10 month(s) ago
Did you know that intravascular and extravascular hemolyses are the 2 hemolytic pathways underlying paroxysmal nocturnal hemoglobinuria (PNH)?
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Not All in Vein: Rare Haematology Disorders Explained - 11 month(s) ago
Morag Griffin joins Jonathan Sackier to discuss rare diseases in haematology and the impact of vaccinations on these conditions.
Source: European Medical JournalCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
📍 Did you know that intravascular and extravascular hemolyses are the 2 hemolytic pathways underlying paroxysmal nocturnal hemoglobinuria? #PNH #RareDisease #CardioX #CME ➡️ https://t.co/mn59CWO8vc https://t.co/3cD0nsVSc1